Publications by authors named "L C Deeb"
Article Synopsis
- Patients with autoimmune diseases, particularly those with inflammatory bowel disease (IBD), face a higher risk of metabolic syndrome (MetS) and cardiovascular disease (CVD), yet research on this is limited.
- A retrospective study examining data from the National Inpatient Sample over five years found that while IBD patients had lower overall prevalence of MetS components compared to non-IBD patients, ulcerative colitis (UC) patients had a higher prevalence than those with Crohn's disease (CD).
- The study demonstrated that higher metabolic scores associated with MetS components were linked to increased risks of acute coronary syndrome and arrhythmias, with significant odds ratios indicating a strong correlation between MetS and heart failure in both IBD types.
Recent Advances in Metal-Oxide-Based Photoresists for EUV Lithography.
Micromachines (Basel)
August 2024
Extreme ultraviolet lithography (EUVL) is a leading technology in semiconductor manufacturing, enabling the creation of high-resolution patterns essential for advanced microelectronics. This review highlights recent progress in inorganic metal-oxide-based photoresists, with a focus on their applications in EUVL. The unique properties of zinc-based, tin-oxygen, and IVB group inorganic photoresists are examined, showcasing their enhanced chemical reactivity and precise patterning capabilities.
View Article and Find Full Text PDFArticle Synopsis
- - Inflammatory myofibroblastic tumors (IMTs) are intermediate malignant mesenchymal tumors that are uncommon in the stomach, primarily affecting young adults, and are often misdiagnosed as other types of tumors.
- - The exact cause of IMTs is not well understood, but it's believed to arise from an exaggerated inflammatory reaction to chronic infections.
- - A case is presented involving a middle-aged woman with a gastric mass who underwent several endoscopic procedures, but her definitive diagnosis of gastric IMT was only achieved after partial gastrectomy and specific immunohistochemistry testing.
Background Nonselective beta-blockers (NSBBs) have been used in the management of portal hypertension and the prevention of initial and recurrent variceal bleeding in patients with liver cirrhosis. However, there is controversy regarding the use of NSBBs in patients with decompensated cirrhosis (DC) due to concerns over potential adverse effects, such as worsening of hepatic function and risk of hepatorenal syndrome (HRS). HRS is a serious complication of DC characterized by acute kidney injury (AKI) and progressive renal failure, and its development can lead to significant morbidity and mortality in this setting.
View Article and Find Full Text PDF